Cancer cell–autonomous metastatic processes can be driven by the genetic landscape of PC, exemplified by the gain-of-function mutation p53R172H, which promotes significantly increased metastasis relative to a genetic loss of p53 in KrasG12D mutant mice (11, 16). The gene discussed is TP53; the disease is cancer.